As of Nov 27
| +0.12 / +2.03%|
The 7 analysts offering 12-month price forecasts for BioDelivery Sciences International Inc have a median target of 14.00, with a high estimate of 20.00 and a low estimate of 7.00. The median estimate represents a +132.17% increase from the last price of 6.03.
The current consensus among 7 polled investment analysts is to Buy stock in BioDelivery Sciences International Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.